Transcriptome-based Identification of Key Actin-binding Proteins Associated with High Metastatic Potential in Breast Cancer

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2024 Sep 16

PMID 39281318

Authors

Christian Muller

Leticia Oliveira-Ferrer

Volkmar Muller

Barbara Schmalfeldt

Sabine Windhorst

Affiliations

Soon will be listed here.

Abstract

Introduction: Actin-binding proteins (ABPs) are essential for the regulation of morphological plasticity required for tumor cells to metastasize. The aim of this study was to perform an unbiased bioinformatic approach to identify the key ABPs significantly associated with the metastatic potential of breast cancer cells.

Methods: Microarray data from 181 primary breast cancer samples from our hospital were used, and all genes belonging to the Gene Ontology term actin cytoskeleton organization were obtained from QuickGO. Association with metastasis-free survival probability was tested using Cox proportional hazards regression, and pairwise co-expression was tested by Pearson correlations. Differential expression between different subgroups was analyzed using Wilcoxon tests for dichotomous traits and Kruskal-Wallis tests for categorical traits. Validation was performed using four publicly available breast cancer datasets.

Results: was significantly associated with a low metastatic potential, and , , and were significantly associated with a high metastatic potential. A significantly higher expression of , and mRNA was found in the more aggressive Her2-positive and triple-negative subtypes as well as in ER-negative samples. Also, these genes were co-expressed in the same tumors. However, only mRNA levels of were increased in pN1 compared to pN0 patients. External validation revealed that and had significant associations with consistent hazard ratios in two breast cancer cohorts, and among these, exhibited the highest hazard ratios.

Conclusion: showed the strongest correlation with the metastatic potential of breast tumors. Thus, targeted inhibition of might be a promising approach to treat malignant breast cancer cells.

References

Leek J, Johnson W, Parker H, Jaffe A, Storey J . The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012; 28(6):882-3. PMC: 3307112. DOI: 10.1093/bioinformatics/bts034. View

Zhang X, Ren D, Guo L, Wang L, Wu S, Lin C . Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer. Breast Cancer Res. 2017; 19(1):15. PMC: 5299657. DOI: 10.1186/s13058-016-0785-2. View

Coumans J, Davey R, Moens P . Cofilin and profilin: partners in cancer aggressiveness. Biophys Rev. 2018; 10(5):1323-1335. PMC: 6233335. DOI: 10.1007/s12551-018-0445-0. View

Barrett T, Wilhite S, Ledoux P, Evangelista C, Kim I, Tomashevsky M . NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2012; 41(Database issue):D991-5. PMC: 3531084. DOI: 10.1093/nar/gks1193. View

Pollard T . Actin and Actin-Binding Proteins. Cold Spring Harb Perspect Biol. 2016; 8(8). PMC: 4968159. DOI: 10.1101/cshperspect.a018226. View

Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, Sarmiento C . Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J Cell Biol. 2007; 179(4):777-91. PMC: 2080932. DOI: 10.1083/jcb.200707009. View

Stevenson R, Veltman D, Machesky L . Actin-bundling proteins in cancer progression at a glance. J Cell Sci. 2012; 125(Pt 5):1073-9. DOI: 10.1242/jcs.093799. View

Lappalainen P, Kotila T, Jegou A, Romet-Lemonne G . Biochemical and mechanical regulation of actin dynamics. Nat Rev Mol Cell Biol. 2022; 23(12):836-852. DOI: 10.1038/s41580-022-00508-4. View

Xu J, Huang Y, Zhao J, Wu L, Qi Q, Liu Y . Cofilin: A Promising Protein Implicated in Cancer Metastasis and Apoptosis. Front Cell Dev Biol. 2021; 9:599065. PMC: 7890941. DOI: 10.3389/fcell.2021.599065. View

10.

Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

11.

Han S, Jin X, Hu T, Chi F . ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loop. Carcinogenesis. 2023; 44(5):369-382. DOI: 10.1093/carcin/bgad042. View

12.

Makowiecka A, Malek N, Mazurkiewicz E, Mrowczynska E, Nowak D, Mazur A . Thymosin β4 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion. Front Cell Dev Biol. 2020; 7:304. PMC: 6935720. DOI: 10.3389/fcell.2019.00304. View

13.

Izdebska M, Zielinska W, Halas-Wisniewska M, Grzanka A . Involvement of Actin and Actin-Binding Proteins in Carcinogenesis. Cells. 2020; 9(10). PMC: 7600575. DOI: 10.3390/cells9102245. View

14.

Wang Y, Klijn J, Zhang Y, Sieuwerts A, Look M, Yang F . Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005; 365(9460):671-9. DOI: 10.1016/S0140-6736(05)17947-1. View

15.

Darb-Esfahani S, Kronenwett R, von Minckwitz G, Denkert C, Gehrmann M, Rody A . Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. Br J Cancer. 2012; 107(11):1892-900. PMC: 3504944. DOI: 10.1038/bjc.2012.475. View

16.

Olson M, Sahai E . The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis. 2008; 26(4):273-87. DOI: 10.1007/s10585-008-9174-2. View

17.

Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt A, Gillet C . Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol. 2007; 25(10):1239-46. DOI: 10.1200/JCO.2006.07.1522. View

18.

Fan S, Yan S, Yang Y, Shang J, Hao M . Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. Onco Targets Ther. 2021; 14:2463-2473. PMC: 8053609. DOI: 10.2147/OTT.S291403. View

19.

Davis S, Meltzer P . GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23(14):1846-7. DOI: 10.1093/bioinformatics/btm254. View

20.

Fares J, Fares M, Khachfe H, Salhab H, Fares Y . Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020; 5(1):28. PMC: 7067809. DOI: 10.1038/s41392-020-0134-x. View